G'day Joe
That's a possibility. Maybe a good option.
Several long term SH's (including moi) have been looking forward to 761 getting into the clinical but it's taken an ice age and still not clinic ready.
No news, updates or known developments. Strange.
761 could be the jewel in the crown - going for the source of autoimmune diseases as opposed to current SOC treating the symptoms.
A possibility - IMM has deliberately held back development of 761? Keep it under BP radar? Use as a bargaining chip?
Lot of questions - and it's all just speculation on my/ our part. But something is brewing IMO.
a current prediction, page-25
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.020(6.56%) |
Mkt cap ! $468.4M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.112M | 3.524M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 11486 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 123774 | 1 |
View Market Depth
| Last trade - 15.59pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |